Synlett 2011(20): 3008-3012  
DOI: 10.1055/s-0031-1289888
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

An Efficient Copper-Catalyzed Microwave-Assisted S-Arylation towards the Synthesis of 8-Arylsulfanyl Adenines

Weilin Suna, Pallav D. Patelb, Ralph A. Stephanib, Gabriela Chiosis*a
a Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Fax: +1(646)4220416; e-Mail: chiosisg@mskcc.org;
b Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, St. John’s University, Jamaica, NY 11439, USA
Further Information

Publication History

Received 24 May 2011
Publication Date:
11 November 2011 (online)

Abstract

We report a microwave-assisted synthetic protocol for the C-S cross-coupling reaction of aryl iodides and 8-mercaptoadenine using CuI and n-Bu4NBr with NaOt-Bu in DMF. The method is rapid, simple, and cost efficient, and leads in high yields to biologically relevant aryl sulfides.

    References and Notes

  • 1a Hartwig JF. In Handbook of Organopalladium Chemistry for Organic Synthesis   Vol. 1:  Negishi E. Wiley-Interscience; New York: 2002.  p.1051 
  • 1b Muci AR. Buchwald SL. Top. Curr. Chem.  2002,  219:  131 
  • 1c Prim D. Campagne J.-M. Joseph D. Andrioletti B. Tetrahedron  2002,  58:  2041 
  • 1d Kondo T. Mitsudo T.-A. Chem. Rev.  2000,  100:  3205 
  • 1e Hartwig JF. Acc. Chem. Res.  1998,  31:  852 
  • 1f Beletskaya IP. Ananikov VP. Eur. J. Org. Chem.  2007,  3431 
  • 2 For general reviews on sulfides, see: Comprehensive Organic Chemistry   Vol. 3:  Jones DN. Pergamon Press; Oxford: 1979. 
  • 3a He H. Zatorska D. Kim J. Aguirre J. Llauger L. She Y. Wu N. Immormino RM. Gewirth DT. Chiosis G. J. Med. Chem.  2006,  49:  381 
  • 3b Chiosis G. Timaul MN. Lucas B. Munster PN. Zheng FF. Sepp-Lorenzino L. Rosen NA. Chem. Biol.  2001,  8:  289 
  • 3c Wang Y. Chackalamannil S. Hu Z. Clader JW. Greenlee W. Billard W. Binch H. Crosby G. Ruperto V. Duffy RA. McQuade R. Lachowicz JE. Bioorg. Med. Chem. Lett.  2000,  10:  2247 
  • 3d Nielsen SF. Nielsen EO. Olsen GM. Liljefors T. Peters D. J. Med. Chem.  2000,  43:  2217 
  • 3e De Martino G. Edler MC. La Regina G. Cosuccia A. Barbera MC. Barrow D. Nicholson RI. Chiosis G. Brancale A. Hamel E. Artico M. Silvestri R. J. Med. Chem.  2006,  49:  947 
  • 3f Kadlor SW. Kalish VJ. Davies JF. Shetty BV. Fritz JE. Appelt K. Burgess JA. Campanale KM. Chirgadze NY. Clawson DK. Dressman BA. Hatch SD. Khalil DA. Kosa MB. Lubbehusen PP. Muesing MA. Patick AK. Reich SH. Su KS. Tatlock JH. J. Med. Chem.  1997,  40:  3979 
  • 3g Marcincal-Letebvre A. Gesquiere C. Lemer C. Dupuis B. J. Med. Chem.  1981,  24:  889 
  • 3h Liu G. Link JT. Pei Z. Reilly EB. Leitza S. Nguyen B. Marsh KC. Okasinski GF. von Geldem TW. Ormes M. Fowler K. Gallatin M.
    J. Med. Chem.  2000,  43:  4025 
  • 3i Gangjee A. Zeng Y. Talreja T. McGuire JJ. Kisliuk RL. Queener SF.
    J. Med. Chem.  2007,  50:  3046 
  • 3j Jarkas N. McConathy J. Voll RJ. Goodman MM. J. Med. Chem.  2005,  48:  4254 
  • 3k Liu L. Stelmach JE. Natarajan SR. Chen M.-H. Singh SB. Schwartz CD. Fitzgerald CE. O’Keefe SJ. Zaller DM. Schmatz DM. Doherty JB. Bioorg. Med. Chem. Lett.  2003,  13:  3979 
  • 3l Beard RL. Colon DF. Song TK. Davies PJA. Kochhar DM. Chandraratna RAS. J. Med. Chem.  1996,  39:  3556 
  • 3m Nagai Y. Irie A. Nakamura H. Hino K. Uno H. Nishimura H. J. Med. Chem.  1982,  25:  1065 
  • 3n Bonnet B. Soullez D. Girault S. Maes L. Landry V. Davioud-Charvet E. Sergheraert C. Bioorg. Med. Chem.  2000,  8:  95 
  • 4a Kondo T. Mitsudo T.-A. Chem. Rev.  2000,  100:  3205 
  • 4b Procter DJ. J. Chem. Soc., Perkin Trans. 1  2001,  335 
  • 4c Ley SV. Thomas AW. Angew. Chem. Int. Ed.  2003,  43:  5400 
  • 5a Itoh T. Mase T. Org. Lett.  2004,  6:  4587 
  • 5b Fernández-Rodríguez MA. Shen Q. Hartwig JF.
    J. Am. Chem. Soc.  2006,  128:  2180 
  • 5c Murata M. Buchwald SL. Tetrahedron  2004,  60:  7397 
  • 5d Mispelaere-Canivet C. Spindler J.-F. Perrio S. Beslin P. Tetrahedron  2005,  61:  5253 
  • 6a Zhang Y. Ngeow KC. Ying JY. Org. Lett.  2007,  9:  3495 
  • 6b Jammi S. Barua P. Rout L. Saha P. Punniyamurthy T. Tetrahedron Lett.  2008,  49:  1484 
  • 6c Taniguchi N. J. Org. Chem.  2004,  69:  6904 
  • 6d Millois C. Diaz P. Org. Lett.  2000,  2:  1705 
  • 7 Wong Y.-C. Jayanth TT. Cheng C.-H. Org. Lett.  2006,  8:  5613 
  • 8 Correa A. Carril M. Bolm C. Angew. Chem. Int. Ed.  2008,  47:  2880 
  • 9 Sperotto E. van Klink GPM. de Vries JG. van Koten G. J. Org. Chem.  2008,  73:  5625 
  • 10a Kasibhatla SR, Hong K, Zhang L, Biamonte MA, Boehm MF, Shi J, and Fan J. inventors; WO  03037860. 
  • 10b Bajji AC, Kim S.-H, Tangallapally R, Markovitz B, Trovatao R, Anderson MB, Wettstein D, and Shenderovich M. inventors; WO  2009065035. 
  • 10c Chen J, Sperl G, Gullo V, Sista L, Hughes D, Peng Y, Pierceall W, Weiskopf A, Dushin RG, and Kevin JI. inventors; WO  2008049105. 
  • 10d Taldone T. Chiosis G. Curr Top Med. Chem.  2009,  9:  1436 
  • 11a Chiosis G. Kang Y. Sun W. Expert Opin. Drug Discovery  2008,  3:  99 
  • 11b Workman P. Burrows F. Neckers L. Rosen N. Ann. N. Y. Acad. Sci.  2007,  1113:  202 
  • 11c Luo W. Rodina A. Chiosis G. BMC Neurosci.  2008,  9:  S7; Suppl. 2 
  • 11d Luo W. Sun W. Taldone T. Rodina A. Chiosis G. Mol. Neurodegener.  2010,  5:  24 
  • 12a Llauger L. He H. Kim J. Aguirre J. Rosen N. Peters U. Davies P. Chiosis G. J. Med. Chem.  2005,  48:  2892 
  • 12b Luo W. Dou F. Rodina A. Chip S. Kim J. Zhao Q. Moulick K. Aguirre J. Wu N. Greengard P. Chiosis G. Proc. Natl. Acad. Sci. U.S.A.  2007,  104:  9511 
  • 12c Cerchietti LC. Lopes EC. Yang SN. Hatzi K. Bunting KL. Tsikitas LA. Malik A. Robles AI. Walling J. Varticovski L. Shaknovich R. Bhalla KN. Chiosis G. Melnick A. Nat. Med.  2009,  15:  1369 
  • 12d Caldas-Lopes E. Cerchietti L. Ahn JH. Clement CC. Robles AI. Rodina A. Moulick K. Taldone T. Gozman A. Guo Y. Wu N. de Stanchina E. White J. Gross SS. Ma Y. Varticovski L. Melnick A. Chiosis G. Proc. Natl. Acad. Sci. U.S.A.  2009,  106:  8368 
  • 12e Marubayashi S. Koppikar P. Taldone T. Abdel-Wahab O. West N. Bhagwat N. Caldas-Lopes E. Ross KN. Gonen M. Gozman A. Ahn JH. Rodina A. Ouerfeli O. Yang G. Hedvat C. Bradner JE. Chiosis G. Levine RL. J. Clin. Invest.  2010,  120:  3578 
  • 13 Tao H. Kang Y. Taldone T. Chiosis G. Bioorg. Med. Chem. Lett.  2009,  19:  415 
  • 14a Kwong FY. Buchwald SL. Org. Lett.  2002,  4:  3517 
  • 14b She J. Jiang Z. Wang Y. Tetrahedron Lett.  2009,  50:  593 
  • 14c Buranaprasertsuk P. Chang JWW. Chavasiri W. Chan PWH. Tetrahedron Lett.  2008,  49:  2023 
  • 15a Bagley MC. Davis T. Dix MC. Fusillo V. Pigeaux M. Rokicki MJ. Kipling D. J. Org. Chem.  2009,  74:  8336 
  • 15b Friden-Saxin M. Pemberton N. da Silva Andersson K. Dyrager D. Friberg A. Grotli M. Luthman K. J. Org. Chem.  2009,  74:  2755 
  • 15c Al-Saleh B. El-Apasery MA. Hilmy NM. Elnagdi MH. J. Heterocycl. Chem.  2006,  43:  1575 
  • 15d Bargiggia FC. Murray WV. J. Org. Chem.  2005,  70:  9636 
  • 15e Xu Y. Guo Q.-X. Heterocycles  2004,  63:  903 
16

General Procedure for the Microwave Coupling Reaction
In a conical-bottomed Biotage microwave vial, the mixture of 8-mercaptoadenine (16 mg, 0.1 mmol), 6-iodo-2,3-benzofuran (24 mg, 0.1 mmol), CuI (3.6 mg, 0.02 mmol), NaOt-Bu (28 mg, 0.3 mmol) and TBAB (6.4 mg, 0.02 mmol) in DMF (2 mL) was charged. The sealed vial was irradiated in the microwave for 1.5 h at 190 ˚C. After cooling, the reaction mixture was condensed in vacuo and purified by flash chromatography (CH2Cl2-MeOH = 10:1) to yield compound 8-(2,3-dihydrobenzofuran-6-ylthio)-9H-purin-6-amine (25 mg, 92%, Table  [²] , entry 1) as a yellow solid.
Analytical Data
¹H NMR (500 MHz, MeOH-d 4): δ = 8.14 (s, 1 H), 7.24 (d, J = 7.6 Hz, 1 H), 7.07 (d, J = 7.3 Hz, 1 H), 6.97 (s, 1 H), 4.62 (t, J = 8.7 Hz, 2 H), 3.25 (t, J = 8.7 Hz, 2 H). ESI-MS: m/z = 285.9 [M + H]+. ESI-HRMS: m/z [M + H]+ calcd for C13H12N5OS: 286.0763; found: 286.0768. HPLC analyses were performed on a Waters Autopurification system with PDA, MicroMass ZQ and ELSD detector and a reversed-phase column (Waters X-Bridge C18, 4.6 × 150 mm, 5 µm). The mobile phase was the mixture of 5-95% MeCN-H2O with 0.1% TFA having a flow rate at 1.2 mL/min for 12 min; t R = 7.47 min; purity, 99%; HRMS data were collected using Waters LCT Premier XE.